However, the S100A10 expression level was not highly noticeable in the invasive breast cancers in our in silico analysis; rather S100A11, S100A14, and S100P were markedly elevated in the cancer tissues compared to those in normal breast tissues (Supplementary Figure 1A). This evidence concerns the gene S100A10 and breast carcinoma.